Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to secrete more insulin and suppressing https://briansidl095754.blog2news.com/36342044/understanding-semaglutide-a-comprehensive-guide